Investigational Gene Therapy for Spinal Muscular Atrophy Gets SAKIGAKE Designation
According to a story from GlobeNewswire, The pharmaceutical company AveXis, Inc., a company that specializes in the development of gene therapies, recently announced that its candidate AVXS-101 was awarded SAKIGAKE…